22-31344986-A-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_014323.3(PATZ1):ā€‹c.617T>Cā€‹(p.Met206Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,461,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 33)
Exomes š‘“: 0.0000062 ( 0 hom. )

Consequence

PATZ1
NM_014323.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.97
Variant links:
Genes affected
PATZ1 (HGNC:13071): (POZ/BTB and AT hook containing zinc finger 1) The protein encoded by this gene contains an A-T hook DNA binding motif which usually binds to other DNA binding structures to play an important role in chromatin modeling and transcription regulation. Its Poz domain is thought to function as a site for protein-protein interaction and is required for transcriptional repression, and the zinc-fingers comprise the DNA binding domain. Since the encoded protein has typical features of a transcription factor, it is postulated to be a repressor of gene expression. In small round cell sarcoma, this gene is fused to EWS by a small inversion of 22q, then the hybrid is thought to be translocated (t(1;22)(p36.1;q12). The rearrangement of chromosome 22 involves intron 8 of EWS and exon 1 of this gene creating a chimeric sequence containing the transactivation domain of EWS fused to zinc finger domain of this protein. This is a distinct example of an intra-chromosomal rearrangement of chromosome 22. Four alternatively spliced transcript variants are described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07242522).
BS2
High AC in GnomAdExome4 at 9 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PATZ1NM_014323.3 linkuse as main transcriptc.617T>C p.Met206Thr missense_variant 1/5 ENST00000266269.10
PATZ1NM_032050.2 linkuse as main transcriptc.617T>C p.Met206Thr missense_variant 1/4
PATZ1NM_032051.2 linkuse as main transcriptc.617T>C p.Met206Thr missense_variant 1/3
PATZ1NM_032052.2 linkuse as main transcriptc.617T>C p.Met206Thr missense_variant 1/5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PATZ1ENST00000266269.10 linkuse as main transcriptc.617T>C p.Met206Thr missense_variant 1/51 NM_014323.3 P1Q9HBE1-1
PATZ1ENST00000351933.8 linkuse as main transcriptc.617T>C p.Met206Thr missense_variant 1/41 Q9HBE1-3
PATZ1ENST00000215919.3 linkuse as main transcriptc.617T>C p.Met206Thr missense_variant 1/31 Q9HBE1-4
PATZ1ENST00000405309.7 linkuse as main transcriptc.617T>C p.Met206Thr missense_variant 1/51 Q9HBE1-2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000616
AC:
9
AN:
1461652
Hom.:
0
Cov.:
32
AF XY:
0.00000550
AC XY:
4
AN XY:
727132
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000809
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 21, 2022The c.617T>C (p.M206T) alteration is located in exon 1 (coding exon 1) of the PATZ1 gene. This alteration results from a T to C substitution at nucleotide position 617, causing the methionine (M) at amino acid position 206 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
20
DANN
Benign
0.88
DEOGEN2
Benign
0.032
T;.;.;.
Eigen
Benign
-0.35
Eigen_PC
Benign
-0.16
FATHMM_MKL
Benign
0.45
N
LIST_S2
Uncertain
0.86
D;D;D;D
M_CAP
Benign
0.0044
T
MetaRNN
Benign
0.072
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;N;N;N
MutationTaster
Benign
0.93
N;N;N;N
PrimateAI
Uncertain
0.75
T
PROVEAN
Benign
-0.74
N;N;N;N
REVEL
Benign
0.11
Sift
Benign
0.089
T;T;T;T
Sift4G
Benign
1.0
T;T;T;T
Polyphen
0.0010
B;B;B;B
Vest4
0.24
MutPred
0.18
Gain of glycosylation at M206 (P = 0.0189);Gain of glycosylation at M206 (P = 0.0189);Gain of glycosylation at M206 (P = 0.0189);Gain of glycosylation at M206 (P = 0.0189);
MVP
0.21
MPC
1.1
ClinPred
0.12
T
GERP RS
4.1
Varity_R
0.17
gMVP
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr22-31740972; API